DE69920039D1 - Quinapril magnesium enthaltende, pharmazeutisch wirksame zusammensetzung - Google Patents

Quinapril magnesium enthaltende, pharmazeutisch wirksame zusammensetzung

Info

Publication number
DE69920039D1
DE69920039D1 DE69920039T DE69920039T DE69920039D1 DE 69920039 D1 DE69920039 D1 DE 69920039D1 DE 69920039 T DE69920039 T DE 69920039T DE 69920039 T DE69920039 T DE 69920039T DE 69920039 D1 DE69920039 D1 DE 69920039D1
Authority
DE
Germany
Prior art keywords
quinapril
pharmaceutic
effective composition
magnesium containing
quinapril magnesium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69920039T
Other languages
English (en)
Other versions
DE69920039T2 (de
Inventor
Bernard Charles Sherman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=19927062&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69920039(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Publication of DE69920039D1 publication Critical patent/DE69920039D1/de
Application granted granted Critical
Publication of DE69920039T2 publication Critical patent/DE69920039T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69920039T 1998-12-08 1999-12-07 Quinapril magnesium enthaltende, pharmazeutisch wirksame zusammensetzung Expired - Lifetime DE69920039T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NZ333206A NZ333206A (en) 1998-12-08 1998-12-08 Solid pharmaceutical compositions comprising a stable magnesium salt of quinapril that acts as a ACE (Angiotensin Converting Enzyme) inhibitor
NZ33320698 1998-12-08
PCT/CA1999/001169 WO2000034314A1 (en) 1998-12-08 1999-12-07 Pharmaceutical compositions comprising quinapril magnesium

Publications (2)

Publication Number Publication Date
DE69920039D1 true DE69920039D1 (de) 2004-10-14
DE69920039T2 DE69920039T2 (de) 2005-09-22

Family

ID=19927062

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69920039T Expired - Lifetime DE69920039T2 (de) 1998-12-08 1999-12-07 Quinapril magnesium enthaltende, pharmazeutisch wirksame zusammensetzung

Country Status (15)

Country Link
US (1) US6531486B1 (de)
EP (1) EP1137662B1 (de)
JP (1) JP5296277B2 (de)
KR (1) KR20010080718A (de)
AT (1) ATE275577T1 (de)
AU (1) AU759889B2 (de)
BR (1) BR9916021A (de)
CA (1) CA2355347C (de)
CZ (1) CZ20012013A3 (de)
DE (1) DE69920039T2 (de)
ES (1) ES2229793T3 (de)
IL (1) IL143652A0 (de)
NZ (1) NZ333206A (de)
WO (1) WO2000034314A1 (de)
ZA (1) ZA200104614B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9910947A (pt) * 1998-06-05 2001-03-06 Warner Lambert Co Estabilização de composições que contêm inibidores de ace utilizando óxido de magnésio
US20030027837A1 (en) * 1998-12-08 2003-02-06 Sherman Bernard Charles Pharmaceutical compositions comprising quinapril magnesium
CA2357982A1 (en) * 2001-09-28 2003-03-28 Bernard Charles Sherman Solid compositions comprising ramipril
WO2005027881A2 (en) * 2003-09-23 2005-03-31 Texcontor Etablissement Stable quinapril compositions
GB201017808D0 (en) 2010-10-21 2010-12-01 Univ Salford The An air spring
GB201405647D0 (en) 2014-03-28 2014-05-14 Carbon Air Ltd Transfer method and apparatus

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL58849A (en) 1978-12-11 1983-03-31 Merck & Co Inc Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them
US4344949A (en) 1980-10-03 1982-08-17 Warner-Lambert Company Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
US4830853A (en) 1986-10-20 1989-05-16 Warner-Lambert Company Drug compositions stabilized against oxidation
US4743450A (en) * 1987-02-24 1988-05-10 Warner-Lambert Company Stabilized compositions
US4761479A (en) * 1987-03-30 1988-08-02 Warner-Lambert Company Crystalline quinapril and a process for producing the same
SI9111842A (sl) 1991-11-25 1998-04-30 Krka Stabilna formulacija soli enalaprila, postopek za njeno pripravo in njena uporaba
US5573780A (en) * 1995-08-04 1996-11-12 Apotex Usa Inc. Stable solid formulation of enalapril salt and process for preparation thereof
BR9910947A (pt) * 1998-06-05 2001-03-06 Warner Lambert Co Estabilização de composições que contêm inibidores de ace utilizando óxido de magnésio

Also Published As

Publication number Publication date
ES2229793T3 (es) 2005-04-16
EP1137662A1 (de) 2001-10-04
NZ333206A (en) 2000-07-28
US6531486B1 (en) 2003-03-11
CA2355347A1 (en) 2000-06-15
CA2355347C (en) 2011-06-21
WO2000034314A1 (en) 2000-06-15
JP2002531577A (ja) 2002-09-24
IL143652A0 (en) 2002-04-21
CZ20012013A3 (cs) 2001-10-17
DE69920039T2 (de) 2005-09-22
JP5296277B2 (ja) 2013-09-25
KR20010080718A (ko) 2001-08-22
AU759889B2 (en) 2003-05-01
EP1137662B1 (de) 2004-09-08
ZA200104614B (en) 2002-06-26
BR9916021A (pt) 2001-10-30
AU1542200A (en) 2000-06-26
ATE275577T1 (de) 2004-09-15

Similar Documents

Publication Publication Date Title
EA199900141A1 (ru) Цветообразующая композиция, содержащая реагент, включающий пирогаллольные структурные фрагменты, соль железа (ii) и органическую кислоту
WO2004017998A3 (en) Topical emulsion- gel composition comprising diclofenac sodium
AR057909A1 (es) Proceso para preparar montelukast y compuestos relacionados, que utiliza un compuesto intermediario derivado de un ester sulfonico.
DE69920039D1 (de) Quinapril magnesium enthaltende, pharmazeutisch wirksame zusammensetzung
DE60236025D1 (de) Pharmazeutische zusammensetzung enthaltend l-arginin
BRPI0410602A (pt) formulações de barreira ao oxigênio
JPS543087A (en) Preparation of cephalosporin compound
EA200101241A1 (ru) Производные индола
GB0212410D0 (en) Organic compounds
AU2003295866A1 (en) Effervescent compositions
BR0109139B1 (pt) composiÇÕes farmacÊuticas incluindo alginatos
JPS535180A (en) Preparation of 3,4-dihydro-2 (1h) quinazoline derivatives
JPS5392767A (en) Preparation of 2-phthalimidomethylindole derivatives
DE60127019D1 (de) Moexipril-Magnesium enthaltende Arzneimittel
RU2002119682A (ru) Аэрозольгенерирующий пиротехнический состав для систем объёмного пожаротушения
EA200000772A1 (ru) Фармацевтические композиции и способы их приготовления
ATE192749T1 (de) Wässrige spectinomycinborat-auflösung
IE38940L (en) Pharmaceutical compositions; salts of p-chlorohippuric acid
RU2000118069A (ru) Добавка в бетонную смесь
JPS53121787A (en) Preparation of oxazolinoazetidinylpentenoic acid derivatives
RU2005105766A (ru) Водно-глицериновый комплекс (2,3-диоксипропил)орто-титанат-силиката "кремнелайф" и фармацевтическая композиция на его основе
JPS53101323A (en) Preparation of 2-substd-2-sulfenyl-1,3-dicarbonyl copound
JPS5276345A (en) Composition of fast curable adhesive
GB1399561A (en) Compounds derived from dioxabicyclooctane-diones and the preparation thereof
JPS545983A (en) Preparation of n'-(2-furanidyl)-5-fluorouracil

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: WITTE, WELLER & PARTNER, 70178 STUTTGART